Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial
- 7 October 2015
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 386 (10012), 2499-2506
- https://doi.org/10.1016/s0140-6736(15)00386-4
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council of Australia (grant 545902)
- Transport Accident Commission of Victoria (grant D162)
This publication has 25 references indexed in Scilit:
- Erythropoietin for Traumatic Brain InjuryJAMA, 2014
- Effect of Erythropoietin and Transfusion Threshold on Neurological Recovery After Traumatic Brain InjuryJAMA, 2014
- Prehospital Rapid Sequence Intubation Improves Functional Outcome for Patients With Severe Traumatic Brain InjuryAnnals of Surgery, 2010
- Clinical Trials in Traumatic Brain Injury: Past Experience and Current DevelopmentsNeurotherapeutics, 2010
- Epidemiology and 12-Month Outcomes From Traumatic Brain Injury in Australia and New ZealandThe Journal of Trauma and Acute Care Surgery, 2008
- The role of erythropoietin in central and peripheral nerve injuryClinical Neurology and Neurosurgery, 2007
- Efficacy and Safety of Epoetin Alfa in Critically Ill PatientsThe New England Journal of Medicine, 2007
- Saline or Albumin for Fluid Resuscitation in Patients with Traumatic Brain InjuryThe New England Journal of Medicine, 2007
- Pathophysiology of Cerebral Ischemia and Brain Trauma: Similarities and DifferencesJournal of Cerebral Blood Flow & Metabolism, 2004
- Science review: Recombinant human erythropoietin in critical illness: a role beyond anemia?Critical Care, 2004